CRSPNasdaq Switzerland
Market cap
$5.175 B
$53.52 +3.64%
Close of 7 Aug 2026
Revenue
$3.51M
#3355 by revenue
Earnings
-$581.6M
Loss-making
Shares outstanding
96,692,653
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for CRISPR Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.